No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis

J Am Acad Dermatol. 2020 Nov;83(5):1436-1439. doi: 10.1016/j.jaad.2020.06.012. Epub 2020 Jun 8.

¹ Psoriasis Center, University Medical Center Schleswig-Holstein, Campus Kiel, Germany.
² Department of Dermatology, Medical University of Vienna, Vienna, Austria; Eli Lilly and Company, Indianapolis, Indiana, USA. Electronic address: riedl_elisabeth@lilly.com.
³ Department of Medicine I, Medical University of Vienna, Vienna, Austria.
⁴ Eli Lilly and Company, Indianapolis, Indiana, USA.
⁵ Department of Dermatology, The Mount Sinai Hospital, New York, New York, USA.

No abstract available

Publication types